MIT Enterprise Forum Pan Arab
alumni directory

Med Predict

Med Predict

Healthcare

Egypt

Still operating

Competition

Competition

Rank

Rank

Track

Track

Arab Startup Competition Twelfth Edition 2019

Semi-finalist

Ideas Track




Competition

Arab Startup Competition Twelfth Edition 2019: Ideas Track - Semi-finalist

Description

Med Predict is a smart software technology startup which uses Artificial Intelligence in the prognosis for cancer disease and suggests a personalized treatment based on the patient’s profile.
The AI-powered prognosis is done through the analysis of multiple data inputs from the patient and then recommending an action plan in terms of what the best type of chemotherapy to be applied, the degree of treatment toxicity to be expected, the overall survival and recurrence risk for each patient according to each patient data profile.
Med Predict not only helps in improving the quality of life for the patients but also will help them live longer through better decision making for the treatment of choice according to his/her data profile. This process, in return, will reduce the financial burden on the patient’s family, and limit the medical complications resulting from the trial-and-error procedures that traditionally happen.

Team members

Hoda Ibrahim / Medical Geneticist
Hoda Yousry Abdallah Ibrahim / CEO
Essam Rashed / Mathematical Modeling Specialist

Reach out

Visit website

Related startups

Phαmo

Medication incompatibilities with herbal remedies, Dietary supplements, primary care items, and othe... Read more

Basma

Basma is a medical device company that is changing lives through better smiles. We re-imagine and re... Read more

Inno Pharma

InnoPharma is a Jordanian start-up, established in (2018). Based on both pharmaceutical marketing ... Read more

Tummy

Tummy is a mobile app which uses machine learning to predict and prevent treating patients who are m... Read more

This site uses cookies to provide you with better user experience and analyze the site traffic. By using our website, you accept our use of cookies.